1. Baur X, Degens PO, Sander I. Baker's asthma: still among the most frequent occupational respiratory disorders. J Allergy Clin Immunol. 1998. 102:984–997.
Article
2. Meredith S. Reported incidence of occupational asthma in the United Kingdom, 1989-90. J Epidemiol Community Health. 1993. 47:459–463.
Article
3. Siracusa A, Kennedy SM, DyBuncio A, Lin FJ, Marabini A, Chan-Yeung M. Prevalence and predictors of asthma in working groups in British Columbia. Am J Ind Med. 1995. 28:411–423.
Article
4. Smith TA, Smith PW. Respiratory symptoms and sensitization in bread and cake bakers. Occup Med (Lond). 1998. 48:321–328.
Article
5. Houba R, Heederik D, Doekes G. Wheat sensitization and work-related symptoms in the baking industry are preventable. An epidemiologic study. Am J Respir Crit Care Med. 1998. 158:1499–1503.
Article
6. Cullinan P, Lowson D, Nieuwenhuijsen MJ, Gordon S, Tee RD, Venables KM, et al. Work related symptoms, sensitisation, and estimated exposure in workers not previously exposed to laboratory rats. Occup Environ Med. 1994. 51:589–592.
Article
7. Houba R, Van Run P, Heederik D, Doekes G. Wheat antigen exposure assessment for epidemiological studies in bakeries using personal dust sampling and inhibition ELISA. Clin Exp Allergy. 1996. 26:154–163.
Article
8. Baur X. Baker's asthma: causes and prevention. Int Arch Occup Environ Health. 1999. 72:292–296.
Article
9. Brisman J. Baker's asthma. Occup Environ Med. 2002. 59:498–502.
Article
10. Palosuo K. Update on wheat hypersensitivity. Curr Opin Allergy Clin Immunol. 2003. 3:205–209.
Article
11. Tiikkainen U, Klockars M. Clinical significance of IgG subclass antibodies to wheat flour antigens in bakers. Allergy. 1990. 45:497–504.
Article
12. Battais F, Pineau F, Popineau Y, Aparicio C, Kanny G, Guerin L, et al. Food allergy to wheat: identification of immunogloglin E and immunoglobulin G-binding proteins with sequential extracts and purified proteins from wheat flour. Clin Exp Allergy. 2003. 33:962–970.
Article
13. Pfeil T, Schwabl U, Ulmer WT, König W. Western blot analysis of water-soluble wheat flour (Triticum vulgaris) allergens. Int Arch Allergy Appl Immunol. 1990. 91:224–231.
Article
14. Hur GY, Koh DH, Kim HA, Park HJ, Ye YM, Kim KS, et al. Prevalence of work-related symptoms and serum-specific antibodies to wheat flour in exposed workers in the bakery industry. Respir Med. 2008. 102:548–555.
Article
15. Malo JL, Chan-Yeung M. Occupational asthma. J Allergy Clin Immunol. 2001. 108:317–328.
Article
16. Reihsaus E, Innis M, MacIntyre N, Liggett SB. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol. 1993. 8:334–339.
Article
17. Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ, et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet. 2004. 364:1505–1512.
Article
18. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry. 1994. 33:9414–9419.
Article
19. Bahn JW, Lee JY, Jang SH, Kim SH, Kim HM, Park HS. Sensitization to Empynase(pronase B) in exposed hospital personnel and identification of the Empynase allergen. Clin Exp Allergy. 2006. 36:352–358.
Article
20. Mehl A, Verstege A, Staden U, Kulig M, Nocon M, Beyer K, et al. Utility of the ratio of food-specific IgE/total IgE in predicting symptomatic food allergy in children. Allergy. 2005. 60:1034–1039.
Article
21. Bernstein IL, Chan-Yeung M, Malo JL, Berstein D. Asthma in the workplace. 1999. 2nd ed. New York: Marcel Dekker Inc..
22. Di Stefano F, Siriruttanapruk S, McCoach J, Di Gioacchino M, Burge PS. Occupational asthma in a highly industrialized region of UK: report from a local surveillance scheme. Eur Ann Allergy Clin Immunol. 2004. 36:56–62.
23. McDonald JC, Keynes HL, Meredith SK. Reported incidence of occupational asthma in the United Kingdom, 1989-97. Occup Environ Med. 2000. 57:823–829.
Article
24. Liggett SB. The pharmacogenetics of beta2-adrenergic receptors: relevance to asthma. J Allergy Clin Immunol. 2000. 105:S487–S492.
25. D'amato M, Vitiani LR, Petrelli G, Ferrigno L, di Pietro A, Trezza R, et al. Association of persistent bronchial hyperresponsiveness with beta2-adrenoceptor (ADRB2) haplotypes. A population study. Am J Respir Crit Care Med. 1998. 158:1968–1973.
26. Israel E, Drazen JM, Liggett SB, Boushey HA, Cherniack RM, Chinchilli VM, et al. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med. 2000. 162:75–80.
Article
27. Cho SH, Oh SY, Bahn JW, Choi JY, Chang YS, Kim YK, et al. Association between bronchodilating response to short-acting beta-agonist and non-synonymous single-nucleotide polymorphisms of beta-adrenoceptor gene. Clin Exp Allergy. 2005. 35:1162–1167.
Article
28. Choudhry S, Ung N, Avila PC, Ziv E, Nazario S, Casal J, et al. Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med. 2005. 171:563–570.
Article
29. Tsai HJ, Shaikh N, Kho JY, Battle N, Naqvi M, Navarro D, et al. Beta 2-adrenergic receptor polymorphisms: pharmacogenetic response to bronchodilator among African American asthmatics. Hum Genet. 2006. 119:547–557.
Article
30. Silverman EK, Kwiatkowski DJ, Sylvia JS, Lazarus R, Drazen JM, Lange C, et al. Family-based association analysis of beta2-adrenergic receptor polymorphisms in the childhood asthma management program. J Allergy Clin Immunol. 2003. 112:870–876.
Article